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The phase variation (reversible on-off switching) of the type 1 fimbrial adhesin of Escherichia coli involves a DNA inversion cata-
lyzed by FimB (switching in either direction) or FimE (on-to-off switching). Here, we demonstrate that RfaH activates expres-
sion of a FimB-LacZ protein fusion while having a modest inhibitory effect on a comparable fimB-lacZ operon construct and on
a FimE-LacZ protein fusion, indicating that RfaH selectively controls fimB expression at the posttranscriptional level. Further
work demonstrates that loss of RfaH enables small RNA (sRNA)MicA inhibition of fimB expression even in the absence of exog-
enous inducing stress. This effect is explained by induction ofE, and henceMicA, in the absence of RfaH. Additional work con-
firms that the procaine-dependent induction ofmicA requires OmpR, as reported previously (A. Coornaert et al., Mol. Micro-
biol. 76:467–479, 2010, doi:10.1111/j.1365-2958.2010.07115.x), but also demonstrates that RfaH inhibition of fimB transcription
is enhanced by procaine independently of OmpR.While the effect of procaine on fimB transcription is shown to be independent
of RcsB, it was found to require SlyA, another known regulator of fimB transcription. These results demonstrate a complex role
for RfaH as a regulator of fimB expression.
Like many adhesins, type 1 fimbriation is controlled by phasevariation (the reversible on-to-off switching in gene expres-
sion that produces a mixed population). fim phase variation in-
volves the site-specific inversion of an300-bp promoter element
(fimS) that contains a promoter for the fimbrial structural genes
(1). Inversion is catalyzed by recombinases FimE (on-to-off
switching) and FimB (low-frequency switching in either direc-
tion), encoded by genes situated adjacent to fimS (2), as well as by
alternative recombinases situated elsewhere in the chromosome
in some pathogenic strains (3, 4).
Regulation of the fim inversion is complex and involves
changes in both recombinase activity and expression. For exam-
ple, the availability of the branched-chain amino acids and alanine
exerts a direct effect on the fim inversion by altering the interac-
tion of the leucine-responsive regulatory protein (Lrp) with the
invertible element (5). In contrast, sialic acid and N-acetylgluco-
samine inhibit fimB expression, and hence FimB recombination,
selectively (6, 7). Moreover, the orientation of fimS controls fimE
expression, ensuring that fimE expression is lower in afimbriate
than fimbriate cells (8, 9). Type 1 fimbriae are a virulence factor in
urinary tract and other infections, and attachment of fimbriate
cells is proinflammatory and facilitates intracellular invasion (10–
12). We have proposed that, by repressing type 1 fimbrial expres-
sion in response to signals like sialic acid, Escherichia coli is better
able to avoid host defenses (6).
NusG and its homolog RfaH regulate transcriptional pausing
and termination. While NusG has a generalized effect on gene
expression and is essential for viability, RfaH is dispensable (13).
RfaH controls the expression of a specific subset of genes in E. coli,
including those involved in lipopolysaccharide (LPS) core biosyn-
thesis (14–16), aswell as virulence factors (17–20).Uropathogenic
E. coli (UPEC) mutants lacking rfaH are attenuated for virulence
in an ascending mouse model of urinary tract infection (21). Re-
markably, RfaH has also been shown to stimulate translation by
binding to protein S10 of the 30S ribosomal subunit (22). Unlike
NusG, both activities of RfaH require the presence of cis-acting ops
(operon polarity suppressor) sites in the DNA that serve to recruit
RfaH to a paused RNA polymerase (RNAP) transcription elonga-
tion complex (13, 23). The ability of RfaH to switch between tran-
scriptional regulator and translational activator involves an un-
precedented refolding of the RfaH carboxy-terminal domain
(RfaH-CTD) from an all- to all- confirmation, enabling RfaH
to bind to ribosomal protein S10 (13).
fimB, which has a sigma 70 promoter, has a large (271-bp) 5=
untranslated region (5= UTR), suggesting that the recombinase
gene may be subject to extensive control following transcription
initiation (24, 25). While this possibility has yet to be investigated
in detail, fimB expression has been shown recently to be inhibited
by the E-dependent small RNA (sRNA) MicA (26). Here, we
report that fimB expression is also enhanced by RfaH and that this
effect requires MicA.
MATERIALS AND METHODS
Bacterial strains and plasmids.The bacterial strains used in this work are
listed in Table 1. All bacterial strains are derivatives of E. coli K-12. To
combine mutant fimB alleles with a FimB-LacZ protein fusion, PCR-gen-
eratedmutantDNAswere first cloned into plasmid pIB347, a derivative of
the temperature-sensitive vector pMAK705 (27), to replace the wild-type
EcoO109I-SphI (1mutation) or SphI-ClaI (2 and3, OLEmutations)
regions. Likewise, to combine the OLEmutation with the fimB-lacZ tran-
scriptional fusion, the mutant DNA was cloned into plasmid pIB342 to
replace the SphI-ClaI region. Allelic exchange was then used to transfer
the mutations from the plasmids into the chromosomal fim region of
strain BGEC043 or KCEC840 using sacB and sucrose counterselection as
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described previously (28). A micA-lacZYA fusion replacing the wild-type
micA gene was constructed by inserting an XbaI fragment containing the
promoterless lacZYA genes isolated from plasmid pIB341 into a micA
vector (pAM011) to generate pAM012. The micA-lacZYA construct was
then transferred into the genome by allelic exchange between pAM012
and strain AAEC100 (MG1655 lacZYA) (28). Strain AAEC189 (fim)
was used as the host strain for recombinant plasmids to ensure that the
DNA was suitably methylated to allow subsequent transformation of the
strain MG1655 (23). P1 transduction was carried out using P1vir as de-
scribed previously (29).
Media and growth conditions. The media included L broth (5 g of
sodium chloride, 5 g of yeast extract, and 10 g of tryptone per liter [Difco])
and L agar (L broth with 1.5% agar [Difco]). Sucrose agar, used to select
recombinant bacteria (13), is L agar supplemented with 6% sucrose in the
absence of sodium chloride. The antibiotics chloramphenicol (25 g/ml)
and kanamycin (25 g/ml) were included in selective media as required
(Sigma). Lactose MacConkey plates (BD) were used as an indicator me-
dium to determine the proportion of switch-on to switch-off bacteria. For
rich defined (RD)medium,minimalMOPS [3-(N-morpholino)propane-
sulfonic acid]mediumwas prepared as described byNeidhardt et al. (30).
The media were supplemented with 10 mM thiamine, 0.4% glycerol,
bases, vitamin B supplement, and amino acids as reported originally by
Neidhardt et al. (30). In experiments that included an rseA mutant con-
trol, the medium was supplemented with 1 mM nicotinic acid. All re-
TABLE 1 Strains used in this study
Strain Relevant characteristics Source/reference
MG1655 K-12 wild type; 	 F	 Fim
 E. coli Genetic Stock Center (CGSC) (47)
AAEC189 YMC9 (	 F	 supE44 hsdR17 mcrA mcrB end A1 thi 1argF-lac-205 fimB-H recA 29
JW0052-1 BW25113 surAKanr CGSC/Keio collection (48)
JW2205 BW25113 rcsBKanr S. Andrews/Keio collection (48)
JW3818 BW25113 rfaHKanr National BioResource Project/Keio
collection (48)
CAG25198 MG1655 lacX74 lambda(rpoHP3-lacZ) nadB::Tn10 rseA C. Gross (49)
CAG45114 MG1655 lacX74 lambda(rpoHP3-lacZ) C. Gross (50)
CAG62192 micACamr C. Gross (26)
AAEC090 MG1655 lacZYA(sacB-Kanr) 28
AAEC100 AAEC090 (sacB-Kanr) 28
AAEC261A MG1655 lacZYA fimB-lacZYA 31
BGEC043 MG1655 lacZYA fimB (	457 [EcoO109I] to
209 [ClaI] relative to fimB ORF)
(sacB-Kanr) lacZYA-3’ fimB
Our unpublished work
BGEC088 MG1655 lacZYA FimE-LacZ 6
BGEC378 MG1655 lacZYA fimA’-RNase III cleavage site-lacZYA fimE-am18 51
BGEC905 MG1655 lacZYA FimB-LacZ 6
KCEC840 MG1655 lacZYA fimB (	1033 [ApaLI] to
209 [ClaI] relative to fimB ORF)
(sacB-Kanr) lacZYA-3’ fimB
34
KCEC1243 BGEC905 slyAKanr 34
KCEC1457 BGEC905 1(fimB 5= UTR	277 bp to	203 bp from fimB ORF) This study
KCEC2862 AAEC261A slyAKanr This study
KCEC3700 BGEC905 rfaHKanr This study
KCEC3858 BGEC905 3(fimB 5= UTR	196 bp to	20 bp from fimB ORF) This study
KCEC3882 BGEC905 3(fimB 5= UTR	196 bp to	20 bp from fimB ORF) rfaHKanr This study
KCEC3890 AAEC261A rfaHKanr This study
KCEC4138 BGEC905 micACamr This study
KCEC4176 BGEC905 micACamr rfaHKanr This study
KCEC4198 BGEC378 rfaHKanr This study
KCEC4202 KCEC2862 slyA This study
KCEC4222 KCEC4204 rfaHKanr This study
KCEC4271 BGEC905 Rm43 (OLE changed from 5= GGCGGTAGTto 5= CCGCTATCA) This study
KCEC4275 BGEC905 Rm43 (OLE changed from 5= GGCGGTAGTto 5= CCGCTATCA) rfaHKanr This study
KCEC4279 BGEC905 Rm43 (OLE changed from 5= GGCGGTAGTto 5= CCGCTATCA) micACamr This study
KCEC4326 BGEC905 2(fimB 5= UTR	196 bp to	58 bp from fimB ORF) This study
KCEC4336 BGEC905 2(fimB 5= UTR	196 bp to	58 bp from fimB ORF) rfaHKanr This study
KCEC4364 BGEC905 1(fimB 5= UTR	277 bp to	203 bp from fimB ORF) rfaHKanr This study
KCEC4370 AAEC261A Rm43 (OLE changed from 5= GGCGGTAGTto 5= CCGCTATCA) This study
KCEC4372 BGEC905 rfaHKanr lacZYArfaH (from 161 bp upstream to 56 bp downstream of
the rfaH ORF)
This study
KCEC4386 BGEC088 rfaHKanr This study
KCEC4412 CAG45114 rfaHKanr This study
KCEC4418 CAG45114 nadB::Tn10 rseA This study
KCEC4420 BGEC905 nadB::Tn10 rseA This study
KCEC4454 AAEC261A rcsBKanr This study
KCEC4484 BGEC905 micACamr nadB::Tn10 rseA This study
KCEC4534 AAEC100 micA-lacZYA This study
KCEC4536 KCEC4534 rfaHKanr This study
KCEC4540 KCEC4534 nadB::Tn10 rseA This study
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agents were obtained from Sigma unless otherwise indicated. Liquid cul-
tures were grown aerobically at 37°C, and culture densities were
monitored spectrophotometrically at 420 or 600 nm.
Analysis of fimB and fimE expression. fimB and fimE expression was
measured using a FimB-LacZ or FimE-LacZ translational fusion or fimB-
lacZ transcriptional fusion situated in the chromosome at fim as described
previously (6, 7, 31). -Galactosidase assays were conducted as described
by us previously (31), following growth in RDmedium at 37°C with rapid
aeration to an optical density at 600 nm (OD600) of approximately 0.2.
Experiments were repeated at least twice, and the values shown in Miller
units represent the mean of at least four samples with 95% confidence
intervals included for each value.
Determination of inversion frequencies. Inversion of the fim switch
was measured following growth in RD medium as described previously
(32). Inversion frequenciesweremeasured by inoculating 25 cultureswith
approximately 0.3 cells per tube. The ratio of on to off cells was estimated
by plating at least five replicates onto lactose-MacConkey indicator me-
dium after approximately 22 generations of growth at 37°C with rapid
aeration.
DNA manipulations. DNA manipulations were carried out using
standard protocols (33). PlasmidDNAwas isolated using theminiprep or
midiprep kit (Qiagen). Restriction enzymes and DNA ligase were pur-
chased from either Promega or New England BioLabs. DNA sequencing
was performed by Source BioScience, Nottingham,UnitedKingdom.Oli-
gonucleotide synthesis was performed byMWG-BiotechAGor byQiagen
Operon, Germany. DNA was amplified by PCR using Pwo polymerase
(Boehringer Mannheim) as described previously (25) or Q5 master mix
(New England BioLabs). Oligonucleotides used in this study are listed in
Table S1 in the supplemental material.
RESULTS
RfaH is a positive regulator of fimB expression. To determine if
RfaH controls fimB expression, a rfaH mutant of strain
BGEC905 (MG1655 lacZYA FimB-LacZ) was constructed by
P1vir transduction. The level of -galactosidase produced by the
mutant was diminished by almost 3-fold relative to the wild type
in this FimB-LacZ protein fusion background (Fig. 1). FimB re-
combination parallels fimB expression closely, and FimB recom-
bination was also diminished around 9-fold in the rfaHmutant as
anticipated (Fig. 2) (6, 7, 34).
In contrast to the FimB-LacZ fusion, expression of a compara-
ble fimB-lacZYA operon fusion increased to a modest extent
(1.2-fold). Likewise, expression of a FimE-LacZ protein fusion
also increased slightly (1.2-fold; data not shown). As a control,
the rfaH-fimB mutant phenotype was complemented by an
ectopic copy of the rfaH gene inserted into the chromosome at lac
(data not shown). As an additional control, the effect of SlyA on
the -galactosidase produced by the two fusions was also mea-
sured (Fig. 1). SlyA activates fimB transcription by inhibiting
H-NS repression, and its loss decreased expression of both fusions
as expected (34). Thus, RfaH affects fimB expressionmainly at the
posttranscriptional level, to produce a net stimulatory effect on
fimB expression.
Identification of a region of the fimB 5= UTR required for
RfaH control. In addition to its effects on transcription termina-
tion, RfaH stimulates translation initiation by binding to protein
S10 of the 30S ribosomal subunit (22). This suggested to us that
RfaH might activate fimB translation directly. Alternatively, we
supposed that RfaH could activate fimB expression indirectly by
FIG 1 The effects of rfaH and slyA mutations on the -galactosidase pro-
duced by FimB-LacZ translational (tl) and fimB-lacZ transcriptional (tc) fu-
sions. The wild-type (wt) and mutant strains indicated were grown and pro-
cessed as described in Materials and Methods.
FIG 2 The effects of rfaH on FimB off-to-on recombination per cell per generation. The bacteria were grown and processed as described in Materials and
Methods. The values shown are the means of at least five measurements.
Moores et al.
150 jb.asm.org Journal of Bacteriology
 o
n
 January 11, 2017 by guest
http://jb.asm.org/
D
ow
nloaded from
 
controlling the expression of posttranscriptional regulator in-
stead.
Direct control by RfaH requires a cis-acting ops (operon polar-
ity suppressor; consensus of 5= R GGCGGTAGYNT) site down-
stream of the transcriptional start site, typically positioned far up-
stream of the translational start site (35, 36). fimB has a large
(271-bp) 5= UTR, and to screen for cis-active sequences required
for RfaH control, three deletions were constructed in this region
and transferred into the chromosome at fim to replace the wild-
type regulatory region of the FimB-LacZ fusion (Fig. 3). The first
deletion (1) extends from immediately adjacent to the 	10 re-
gion of the fimB promoter (	277 bp to 	203 bp relative to the
fimB open reading frame [ORF]) to an SphI restriction endonu-
clease site. The second (2) and third (3) deletions extend from
the SphI site to 	58 bp and 	20 bp relative to the fimB ORF,
respectively. The best match (5=AAGGGA) to the consensus
Shine-Dalgarno sequence (5= AGGAGG) extends from	12 bp to
	7 bp relative to the fimB ORF.
All of the deletion mutations increased the expression of the
FimB-LacZ fusion to a greater or lesser extent, suggesting that the
long intergenic region of fimB has a detrimental effect on fimB
expression overall (Fig. 4). While the 1 mutation increased the
response to RfaH considerably (3-fold in the wild type to 7-fold in
the mutant), the 2 mutation decreased the response to RfaH to
2-fold and the 3 mutation eliminated it almost entirely.
Effect of RfaH on MicA inhibition of fimB expression. The
E-controlled regulatory sRNA MicA inhibits fimB expression
(26). The mRNA binding target for MicA lies immediately up-
stream of the fimB Shine-Dalgarno sequence (extending from	9
to 	46) and is thus conserved in its entirety in the 2 mutation
but absent from the 3 mutation (Fig. 3). These observations
suggested to us that RfaHmight activate fimB expression by some-
howpreventingMicA inhibition. AlthoughMicA surprisingly had
a net stimulatory effect on fimB expression in the wild-type back-
ground, mutation of micA nevertheless suppressed the stimula-
tory effect of RfaH on fimB expression entirely (Fig. 5). As a con-
trol, the effect of RseA on fimB expression was also tested. RseA
prevents induction of the E regulon by sequestering the sigma
factor to the inner membrane (37). As expected, fimB expression
was inhibited strongly in the rseA mutant background and this
effect was also suppressed in an rseA micA double mutant. The
results of these experiments thus support the conclusion that
RfaH somehow prevents MicA inhibition of fimB expression.
Loss of RfaH induces micA and rpoHP3 expression. The re-
sults described above suggested that RfaHmight exert an indirect
effect on fimB expression by controlling micA expression. To test
this hypothesis, the effect of both RfaH and RseA on expression of
amicA-lacZ transcriptional fusion was determined. The results of
this experiment (Fig. 6) demonstrate that loss of RfaH results in
the induction of micA transcription, albeit to a lesser extent than
that observed in the rseA mutant background (5-fold versus
13-fold).
We supposed either that RfaH could activate micA expression
directly or that, more likely, its loss leads to induction of the E
regulon in general. To distinguish between these possibilities, the
effect of RfaH on expression of the E-specific rpoHP3 promoter
(38) was also tested (Fig. 7). As expected, expression of the
rpoHP3-lacZ construct was induced significantly by mutation of
rseA (27-fold). Mutation of rfaH had a smaller (10-fold) effect,
consistent with the more modest effect of RfaH on both fimB and
micA expression.
Notwithstanding the results described above, it still seemed
possible that RfaHmight also exert a direct effect on fimB expres-
sion by binding to an ops-like element in the fimB 5= UTR. This
seemed plausible because the 2 mutation, which removes a sig-
nificant part of the 5=UTR, diminished the effect of RfaH on fimB
expression (Fig. 4). Moreover, a search of the 5= UTR of fimB
highlighted a potential ops-like site (5= TGGCGTTTGTAT; non-
ops-matching bases underlined) positioned around 180 bp up-
stream of the fimB translational start (Fig. 3). This ops-like se-
quence (here termed OLE for ops-like element) lies 8 bp
downstream of the SphI site present in the fimB 5=UTR and hence
is deleted in both the 2 and 3 mutants. However, the effect of
rseA on fimB expression was also decreased from10-fold in the
wild-type background to4-fold in the 2 mutant background,
suggesting that the 2 mutation diminishes the effect of MicA on
fimB expression (data not shown). Moreover, while mutation of
OLE from 5= TGGCGTTTGTAT to TCCGCTATCAAT did de-
crease fimB expression 8-fold, this effect did not require RfaH
(data not shown). Furthermore, the OLEmutation also decreased
the expression of the fimB-lacZ transcription fusion (data not
shown), which mutation of rfaH does not (Fig. 1). We thus con-
clude that loss of RfaH leads to induction of E, and hence micA,
and that this effect accounts for most, if not all, of the stimulatory
effect of RfaH on fimB expression.
The effect of procaine on fimB expression and FimB recom-
bination. E, and hence MicA, is induced by procaine and by
FIG 3 The organization of the fimB promoter and 5= UTR. The extents of
deletionmutations1 to3 are indicated by solid lines. Also indicated are the
positions of the MicA target sequence in the fimB mRNA (26), the predicted
fimB Shine-Dalgarno sequence (SD), and the ops site-like element OLE. The
fimB promoter	35 and	10 regions (shaded rectangles), transcriptional start
site and direction (arrow), and previously characterized SlyA binding sites
OSA1 and OSA2 (34) are also shown. The start of the fimB ORF is indicated by
the labeled box. Sp (SphI) and EO (EcoO109I) correspond to the restriction
endonuclease sites used in this study. The ClaI site used lies within the fimB
ORF further downstream than the region included in the diagram. The scale of
the diagram (100 bp) is indicated by an additional horizontal line. The parallel
diagonal lines denote that OSA1 and OSA2 lie further upstream of the fimB
promoter than indicated by the linear scale of the diagram.
FIG 4 The effects of 1 to 3 mutations on the -galactosidase produced by
a FimB-LacZ fusion. The wild-type (wt) and mutant strains indicated were
grown and processed as described in Materials and Methods.
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ethanol (39, 40). As noted above, although MicA had a net stim-
ulatory effect on fimB expression under noninducing conditions
(Fig. 5), inclusion of increasing amounts of procaine (Fig. 8) or of
ethanol (data not shown) led to a dose-dependent decrease in
fimB expression as expected. FimB recombination was also inhib-
ited by procaine as anticipated (Fig. 9). Procaine induces E by
activating the EnvZ-OmpR two-component regulatory system
(39). In agreement with this assertion, the effect of procaine on
fimB expression was also diminished in an ompR mutant back-
ground. Moreover, the level of fimB expression in a micA ompR
doublemutant was indistinguishable from that in the ompR single
mutant background (data not shown).
Surprisingly, inhibition of fimB expression by both procaine
(Fig. 8) and ethanol (data not shown) was still apparent, albeit to
a decreased extent, in the micA mutant background. Unexpect-
edly, RfaH actually inhibited fimB expression in the absence of
MicA under E-inducing conditions. Further work demonstrated
that procaine also inhibits expression of the fimB-lacZ transcrip-
tional fusion and that this effect requires RfaH (Fig. 10) but not
OmpR (data not shown).
The results described above suggest that procainemight trigger
an alternative envelope stress response pathway that is also con-
trolled byRfaH.According to this scenario, we supposed that both
procaine and RfaH activate the pathway and that the cognate reg-
ulator of the system inhibits fimB transcription. It has been shown
previously that fimB transcription is controlled by the response
regulator RcsB that forms part of the Rcs phosphorelay system, a
regulatory pathway that is also responsive to envelope stress (41).
However, it was found that fimB transcription was unaffected by
RcsB under the growth conditions used in this study and that the
effect of procaine on the expression of the fimB-lacZ transcrip-
tional fusion remained intact in thismutant background (data not
shown). In contrast, the response of fimB transcription to pro-
caine was found to be dependent upon SlyA (Fig. 10). Further-
more, the inhibitory effect of RfaH on fimB transcription was en-
hanced in the slyA mutant background.
FIG 5 The effects of micA, rfaH, and micA rfaH double mutations on the -galactosidase produced by a FimB-LacZ fusion. The wild-type (wt) and mutant
strains indicated were grown and processed as described inMaterials andMethods, except that the growthmedium used contained 1mMnicotinic acid to allow
growth of the rseA mutants which contain a linked nadB::Tn10 mutation.
FIG 6 The effects of rfaH and rseA on the -galactosidase produced by a
micA-lacZ fusion. Thewild-type (wt) andmutant strains indicatedwere grown
and processed as described in Materials and Methods, except that the growth
medium used contained 1 mM nicotinic acid to allow growth of the rseA
mutants which contain a linked nadB::Tn10 mutation.
FIG 7 The effect of rfaH and rseA on the -galactosidase produced by a
rpoHP3::lacZ fusion. The strains indicated were grown and processed as de-
scribed in Materials and Methods, except that the growth medium used con-
tained 1mMnicotinic acid to allow growth of the rseAmutants which contain
a linked nadB::Tn10 mutation.
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The results presented above are consistent with ourmodel that
RfaH activates fimB expression by preventing MicA inhibition.
However, they also suggest that RfaH can, at least in the presence
of procaine, somehow inhibit fimB transcription by a mechanism
that involves neither OmpR nor RcsB but which does require
SlyA. These results highlight the complexity of the RfaH regula-
tory circuit that controls fimB expression.
DISCUSSION
RfaH-binding ops elements are characteristically found in long 5=
UTRs, far upstream of ORFs. Moreover, UPEC mutants lacking
rfaH are attenuated for virulence in an ascending mouse model of
urinary tract infection (21). Since fimB has a relatively large (271-
bp) 5= UTR and type 1 fimbriation is a virulence factor in the
mouse model, we considered it possible that RfaH is an activator
of fimB expression. Here, we demonstrate that RfaH does indeed
enhance fimB expression, but further analysis reveals that this ef-
fect is indirect.
In support of the hypothesis that RfaH enhances fimB expres-
sion, it was found in an initial experiment that expression of a
FimB-LacZ protein fusion was diminished around 3-fold in an
rfaHdeletionmutant. Surprisingly, however, expression of a com-
parable fimB-lacZ transcriptional fusion was elevated slightly in
the absence of RfaH, indicating that RfaH activates fimB expres-
sion selectively at the posttranscriptional level.Moreover, deletion
analysis of the fimB 5=UTR indicated that, rather than requiring
sequences far upstream of the fimB ORF, RfaH control is de-
pendent upon sequences close to the ribosome binding site.
Further work demonstrates that RfaH activates fimB expres-
sion indirectly by controlling induction of E and hence the
sRNA MicA (Fig. 11).
In addition to controlling the expression of a number of viru-
lence factors, RfaH enhances expression of the waaQ operon re-
quired for LPS core biosynthesis (15, 16). Alterations to LPS core
biosynthesis, apparently by inducing misfolding of outer mem-
brane proteins, can also induceE (42).While not proven here, we
postulate that induction of E in the rfaH mutant reflects the
involvement of RfaH in LPS biosynthesis (Fig. 11). We note that
the increased autoaggregation factor antigen 43 (Ag43)-enhanced
biofilm formation observed in an rfaH mutant background was
also attributed in part to changes in LPS biosynthesis (17).
The effect of procaine onE induction, andhencemicA expres-
sion, was reported previously to be dependent upon OmpR (39).
Our results agree with this since the effect of procaine on fimB
expression was diminished in an ompR mutant and the level of
fimB expression in the micA ompR double mutant was indistin-
guishable from that of the ompR single mutant across the range of
procaine levels (0 to 20 mM) tested (data not shown). Surpris-
ingly, the residual effect of procaine on fimB expression in amicA
mutant is largely dependent on RfaH (Fig. 8). Further work shows
that procaine inhibits expression of the fimB-lacZ transcriptional
fusion as well and that this effect requires RfaH (Fig. 10) but not
OmpR (data not shown).We suppose that this additional effect of
procaine involves an alternative stress-response pathway and an
unidentified transcriptional repressor (Rx) (Fig. 11). RfaH has
also been shown somehow to inhibit transcription of flu, which
encodes Ag43 (17). This effect, which is due neither to changes in
fluphase variation per senor to altered control by known regulator
OxyR or Dam, suggests that fimB and flu transcription may both
be repressed by Rx.
The effect of RfaH and procaine on fimB transcription is not
dependent upon OLE (data not shown). Moreover, we have also
FIG 8 The effects of micA, rfaH, and micA rfaH double mutations on the -galactosidase produced by a FimB-LacZ fusion in the presence and absence of
procaine. Procaine was included at the concentrations (0 to 20 mM) specified. The wild-type (wt) and mutant strains indicated were grown and processed as
described in Materials and Methods.
FIG 9 The effects of procaine on FimB off-to-on recombination per cell per
generation. Procaine was included at the concentrations (0 to 20 mM) speci-
fied. The wild-type strain was grown and processed as described in Materials
and Methods. The values shown are the means of at least five measurements.
RfaH Suppresses MicA Inhibition
January 2014 Volume 196 Number 1 jb.asm.org 153
 o
n
 January 11, 2017 by guest
http://jb.asm.org/
D
ow
nloaded from
 
ruled out involvement of the Rcs phosphorelay system, which has
been reported to control fimB expression and which is also re-
sponsive to envelope stress (data not shown) (41). On the other
hand, the effect of procaine on fimB transcription requires SlyA
(Fig. 10). Although these results are open to interpretation, we
favor a model in which RfaH is necessary for expression of the
alternative stress-response pathway while loss of SlyA leads to its
constitutive activation (Fig. 11). We suppose that SlyA activates
the expression of an additional unidentified factor (Fx) that some-
how alters the signaling pathway tomake it responsive to procaine
(Fig. 11).
Type 1 fimbriae, which are anchored in the bacterial outer
membrane, facilitate the delivery of LPS to the TLR4 signaling
pathway in CD14-negative epithelial cells (10). Furthermore, in
contrast to phase-locked-off bacteria, MicA inhibits fimB expres-
sion in phase-locked-on fimbriate cells even in the absence of
exogenous inducers ofE (our unpublished data). This suggests to
us that fimbrial biosynthesis itself imposes significant stress on the
outer membrane, as has been reported for other outer membrane
proteins (38). We thus propose that suppressing fimB expression,
and hence type 1 fimbriation, in response to the integrity of the
bacterial outermembrane is an adaptation that enhances bacterial
survival both by diminishing envelope stress and by limiting the
host inflammatory response. The fact that RybB, a second E-
dependent sRNA, inhibits fimA expression would provide an ad-
ditional mechanism to limit fimbrial expression in phase-on bac-
teria (26). Indeed, we suppose that this explains why nonfimbriate
cells are produced even when fimS is locked in the on phase, or
when fimS is replaced with the isopropyl--D-galactopyranoside
(IPTG)-inducible tac promoter (43). Mutation of surA also in-
duces E (44), and as expected, we have found that fimB expres-
sion was also decreased in a surAmutant (data not shown). While
SurA enhances the correct localization of the fim usher (FimD) to
the outer membrane, our results indicate that decreased fimB ex-
pression, and hence off-to-on inversion of fimS, as well as induc-
tion of rybB, also contributed to diminished type 1 fimbriation
observed in a surA mutant (45).
A BLAST search of the nucleotides of the fimB mRNA pre-
dicted to bind to MicA demonstrates that these sequences are
perfectly conserved in all of the E. coli strains for which DNA
sequence data are available. Thus, the regulation of fimB expres-
sion byMicA, and its control by factors such as RfaH and SurA, is
likely to have general significance for the control of type 1 fimbri-
ation inmost, if not all, E. coli strains. Further workwill determine
how RfaH controls E, as well as the response of fimB transcrip-
tion to procaine, and the full extent of these control pathways on
type 1 fimbriation in commensal and pathogenic strains alike.
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FIG 10 The effects of rfaH and slyA mutations on the -galactosidase produced by a fimB-lacZ transcriptional fusion in the presence and absence of procaine.
Procaine was included at the concentrations (0 to 20 mM) specified. The wild-type (wt) and mutant strains indicated were grown and processed as described in
Materials and Methods.
FIG 11 Model for the control of fimB expression and type 1 fimbriation by
RfaH and MicA. (a) Misfolded outer membrane proteins (MOMP) activate
protease DegS to cleave RseA, releasing E to activate micA transcription (37,
46). (b) Procaine (Pc) activates EnvZ/OmpR to also induceE and hencemicA
expression (39). (c) Mutation of rfaH also leads to changes in LPS core bio-
synthesis that cause misfolding of outer membrane proteins and hence induc-
tion of E and hence micA expression. (d) Procaine activates an alternative
envelope stress pathway (Sx-Rx). (e) RfaH is postulated to inhibit fimB tran-
scription indirectly by activation expression of Sx and/or Rx. (f and g) SlyA
enhances fimB expression directly (34) (f) but is also postulated (g) to enhance
expression of an unknown factor (Fx) that prevents Sx-Rx signaling in the
absence of procaine. (h) FimB catalyzes off-to-on inversion of fimS to enhance
expression of type 1 fimbriae (T1F). (i) Type 1 fimbriae stimulate inflamma-
tion by enhancing LPS-activated host signaling pathways (10–12). Stimulatory
and inhibitory interactions are indicated by arrows and diamonds, respec-
tively. Dotted lines represent speculative pathways. OM, outermembrane; IM,
inner membrane.
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